FILE PHOTO: Russian S-400 missile air defence systems are seen during a training exercise in Kaliningrad region
stock share market news live
30-303835_zee-business-zee-business-channel-logo-png-clipart

Axis Direct picks Balrampur Chini, Biocon and other stocks for 15 days

ZeeBiz Desk

Sep 16,2024
FILE PHOTO: Russian S-400 missile air defence systems are seen during a training exercise in Kaliningrad region
stocks news
30-303835_zee-business-zee-business-channel-logo-png-clipart

Sensex jumped 97.84 points to settle at an all-time closing high of 82,988.78 today while Nifty was 27.25 points up at 25,383.75.

FILE PHOTO: Russian S-400 missile air defence systems are seen during a training exercise in Kaliningrad region
stocks-trading
30-303835_zee-business-zee-business-channel-logo-png-clipart

Brokerage Axis Direct has chosen five stocks for positional traders. These stocks include Vinati Organics, JSW Steel, Balrampur Chini, Biocon, and Strides Pharma. Let's take a look at their target prices.

stocks-buy

Vinati Organics share price target

Axis Direct has given a 'buy' rating on Vinati Organics. The brokerage has given a target of Rs 2,089 and a stop loss of Rs 1,913. This means the stock has an upside of seven per cent from its last closing price.

large cap midcap smallcap stocks

Share price target JSW Steel

Axis Direct has given a 'buy' rating on JSW Steel. The brokerage has given a target of Rs 1,026 and a stop loss of Rs 950. This means the stock has an upside of six per cent from its last closing price.

best-shares-stocks-buy-today

Balrampur Chini share price target

Axis Direct has given a 'buy' rating on Balrampur Chini. The brokerage has given a target of Rs 638 and a stop loss of Rs 560. This means the stock has an upside of 12 per cent from its last closing price.

long-term-stock-recommendations

Share price target Biocon

Axis Direct has given a 'buy' rating on Biocon. The brokerage has given a target of Rs 409.20 and a stop loss of Rs 382. This means the stock has an upside of five per cent from its last closing price.

stock-trading-workplace-background (1)

Strides Pharma share price target

Axis Direct has given a 'buy' rating on Strides Pharma. The brokerage has given a target of Rs 1,550 and a stop loss of Rs 1,369. This means the stock has an upside of 11 per cent from its last closing price.

investment_calculator_pexels

The views/suggestions/advice expressed here in this article are solely by the brokerage firm. Zee Business suggests its readers consult their investment advisers before making any financial decision.